Top
image credit: Adobe Stock

Common Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says

August 12, 2022

Via: Drugs.com
Category:

The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administration announced this week.

Despite the discovery that Nitroso-STG-19 (NTTP) had been found in some samples of the drug, known generically as sitagliptin, “it could be dangerous for patients with this condition to stop taking their sitagliptin without first talking to their health care professional,” the FDA explained in its alert.

Read More on Drugs.com